- 1,223$1.6B
1
- 3,900$7.9B
2
- 1,402$698.8M
3
- 1,300$438.8M
4
- 740$103.1M
5
- 3,045$1.9B
6
Incyte - Business Information
Manufacturing · Delaware, United States · 2,094 Employees
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.Read More
View Company Info for Free
Who is Incyte
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Top Competitors of Incyte
Incyte Org Chart
Incyte Company Metrics
Apr 10, 2021
Villaris Therapeutics
See More Acquisitions & Subsidiaries
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Incyte News & Media
How the New Castle County's planning process could affect Incyte's office project
A proposal from the county's Land Use Department would affect what can be built on multiple properties.AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in OncologyIncyte to Present at Upcoming Investor Conferences
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September: Wells Fargo 2023 Healthcare Conference on Thursday, September 7, 2023 at 8:45 am (EDT) Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 at 11:20 am (EDT) Bank of America 2023 Global Healthcare Conference on Thursday, September 14, 2023 at 8:15 am (BST) The presentations will be webcast live and canIncyte Corporation's (NASDAQ:INCY) Stock Is Going Strong: Have Financials A Role To Play?
Incyte's (NASDAQ:INCY) stock is up by a considerable 6.8% over the past month. We wonder if and what role the company's...
Frequently Asked Questions regarding Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome... Read More